Yung Zip Chemical Ind Co Ltd
Yung Zip Chemical Ind. Co., Ltd. operates as a bulk drug manufacturing company worldwide. It offers active pharmaceutical ingredients (APIs) and excipients, API intermediates, and specialty chemicals, as well as custom research and manufacturing services. The company was founded in 1978 and is based in Taichung, Taiwan.
Market Cap & Net Worth: Yung Zip Chemical Ind Co Ltd (4102)
Yung Zip Chemical Ind Co Ltd (TWO:4102) has a market capitalization of $24.91 Million (NT$824.17 Million) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #25849 globally and #1613 in its home market, demonstrating a -2.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yung Zip Chemical Ind Co Ltd's stock price NT$19.45 by its total outstanding shares 42374000 (42.37 Million).
Yung Zip Chemical Ind Co Ltd Market Cap History: 2015 to 2026
Yung Zip Chemical Ind Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $27.78 Million to $24.91 Million (0.22% CAGR).
Yung Zip Chemical Ind Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yung Zip Chemical Ind Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Yung Zip Chemical Ind Co Ltd's market cap is 0.07 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.61x
Yung Zip Chemical Ind Co Ltd's market cap is 0.61 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $27.78 Million | $317.57 Million | -$27.65 Million | 0.09x | N/A |
| 2016 | $20.66 Million | $268.09 Million | -$68.33 Million | 0.08x | N/A |
| 2017 | $19.81 Million | $314.37 Million | -$24.96 Million | 0.06x | N/A |
| 2018 | $16.73 Million | $357.09 Million | -$14.96 Million | 0.05x | N/A |
| 2019 | $19.81 Million | $416.84 Million | $31.32 Million | 0.05x | 0.63x |
| 2020 | $31.41 Million | $463.21 Million | $30.74 Million | 0.07x | 1.02x |
| 2021 | $23.67 Million | $477.60 Million | $6.00 Million | 0.05x | 3.94x |
| 2022 | $44.03 Million | $567.33 Million | $69.99 Million | 0.08x | 0.63x |
| 2023 | $49.75 Million | $559.15 Million | $62.51 Million | 0.09x | 0.80x |
| 2024 | $39.70 Million | $583.70 Million | $64.61 Million | 0.07x | 0.61x |
Competitor Companies of 4102 by Market Capitalization
Companies near Yung Zip Chemical Ind Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Yung Zip Chemical Ind Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Yung Zip Chemical Ind Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Yung Zip Chemical Ind Co Ltd's market cap moved from $27.78 Million to $ 24.91 Million, with a yearly change of 0.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$24.91 Million | -2.02% |
| 2025 | NT$25.42 Million | -35.97% |
| 2024 | NT$39.70 Million | -20.19% |
| 2023 | NT$49.75 Million | +12.98% |
| 2022 | NT$44.03 Million | +85.99% |
| 2021 | NT$23.67 Million | -24.62% |
| 2020 | NT$31.41 Million | +58.54% |
| 2019 | NT$19.81 Million | +18.41% |
| 2018 | NT$16.73 Million | -15.55% |
| 2017 | NT$19.81 Million | -4.09% |
| 2016 | NT$20.66 Million | -25.65% |
| 2015 | NT$27.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Yung Zip Chemical Ind Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.91 Million USD |
| MoneyControl | $24.91 Million USD |
| MarketWatch | $24.91 Million USD |
| marketcap.company | $24.91 Million USD |
| Reuters | $24.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.